Introduction
============

High anxiety levels are frequently associated with alterations in individuals' social behaviors.^[@bib1]^ Emerging evidence indicates that this is particularly the case in competitive settings, where anxious individuals frequently show reduced competitiveness^[@bib2],\ [@bib3],\ [@bib4]^ and consequently adopt a subordinate status.^[@bib5]^ This notion is in line with the increased risk to develop psychopathologies by high-anxious individuals^[@bib6]^ as lower rank in society and social organizations has been related to impaired physical and mental health.^[@bib7],\ [@bib8],\ [@bib9]^

Benzodiazepines, the prototypic wide-spectrum anxiolytic drugs, have long been shown to effectively increase social competitiveness in a range of species (from non-human primates^[@bib10]^ and rodents^[@bib11]^ to pigeons^[@bib12]^). However, the neural circuits and mechanisms whereby benzodiazepines affect social competition are largely unknown. Given the various side effects, particularly those of habituation and addiction, associated with the long-term use of benzodiazepines,^[@bib13]^ understanding the neurobiological processes whereby benzodiazepine treatment influences social behaviors could further the design of less harmful therapeutic solutions for anxiety-related deficits in the social domain.

Converging evidence points to the mesolimbic system as a potential site of action for the facilitating effect of benzodiazepines in social dominance. First, benzodiazepines have been shown to act at the ventral tegmental area (VTA), where they are believed to mediate their addictive effects.^[@bib14]^ Specifically, through positive modulation of the ϒ-aminobutyric acid type A receptors (GABAaRs) and the consequent disinhibition of dopamine neurons, benzodiazepine actions in the VTA were shown to increase dopaminergic function in the nucleus accumbens (NAc).^[@bib14],\ [@bib15],\ [@bib16]^ This is in agreement with early evidence that activation of VTA GABAaRs increases DA release in the NAc.^[@bib17]^ Secondly, the VTA to the NAc neural---particularly dopaminergic---projections have been implicated in a variety of behavioral processes that likely contribute to the establishment of social dominance, from reward processing to different aspects of behavioral activation---including motivation, exertion of effort, seeking and energy expenditure and 'vigor' of behavior.^[@bib18],\ [@bib19],\ [@bib20],\ [@bib21],\ [@bib22],\ [@bib23],\ [@bib24]^ Third, the NAc appears to be critically activated in social competitive settings, as shown for human-^[@bib25],\ [@bib26],\ [@bib27]^ and non-human primates^[@bib28],\ [@bib29]^ and for rodents.^[@bib4],\ [@bib30]^ Furthermore, we recently established a causal role for mitochondrial function in the NAc linking anxiety and social competition.^[@bib4]^

Here, we investigated whether diazepam can enhance social competition through direct actions in the VTA and explored downstream mechanisms of action, particularly mitochondrial respiration and the accumbal dopaminergic system. Our data demonstrate the ability of diazepam to facilitate social dominance---including the reversal of the competitive disadvantage displayed by high-anxious animals---and enhance mitochondrial function in the NAc in rats in a D1 receptor-dependent manner. Our findings implicate increased dopamine release from the VTA along with the engagement of NAc D1 receptors in the NAc in these facilitating effects.

Materials and methods
=====================

Animals
-------

Adult male Wistar rats (Charles River, L'Arbresle, France) weighing 250--275 g at the start of experiments were used. Animals were individually housed in polypropylene cages (57 × 35 × 20 cm) with abundant pine bedding in a temperature- (23 °C) and light- (lights on from 0700 to 1900 hours) controlled room. All animals had *ad libitum* access to standard food and water. Upon arrival to the facility, animals were allowed to habituate to the vivarium for 1 week and were then handled for 2 min/day during 3 days before the start of all experiments. All behavioral manipulations were performed during the light phase by experimenters blind to treatment groups. All experiments were performed with the approval of the Cantonal Veterinary Authorities (Vaud, Switzerland) and carried out in accordance with the European Communities Council Directive of 22 September 2010 (2010/63/EU).

The elevated plus maze, intracerebral surgery, pharmacology, social preference test, social dominance test, mitochondrial respirometry, high-performance liquid chromatography, microdialysis, immunohistochemistry, as well as protein, mtDNA and gene expression were all performed following the procedures detailed in the [Supplementary Materials and Methods](#sup1){ref-type="supplementary-material"}. All efforts were made to minimize the number of animals while maintaining statistical rigor.

Statistical analyses
--------------------

Samples sizes (*N*) are indicated in figure legends and represent biological replicates only. Sample sizes were based on pilot experiments and our previous work.^[@bib4]^ Animals were characterized (depending on the experiment) and randomly allocated to groups. Investigators were blinded to the groups during the experiment and assessment. Unpaired two-tailed student's *t*-tests were used to compare sets of data obtained from independent groups of animals except for the correlational data between mitochondrial complex activity and social dominance ([Supplementary Figure 4](#sup1){ref-type="supplementary-material"}), where we had *a priori* expectations regarding linkage direction. Within-pair amounts of behavior in the social dominance test were compared using paired two-tailed student's *t*-tests. In sets of data in which animals were matched for anxiety, relative social dominance scores were compared using one-sample *t*-tests against chance (50%). In sets of data in which comparisons were performed against the vehicle-treated control, data from experimental animals were normalized to control values and compared using one-sample *t*-tests. All data had similar variances apart from protein kinase A (PKA) phosphorylated protein data (Figure 2j), which was analyzed using a Welch's correction. All data---except for mitochondrial respiration---were analyzed using Prism version 5.01 (Graphpad Software, San Diego, CA, USA) and are presented as the mean±s.e.m. For respiration experiments, data were analyzed using SPSS statistical software version 13.0 (SPSS, Chicago, IL, USA). As experiments were performed in blocks across days, a linear mixed model was created that included block as a random effect in addition to fixed effects of either anxiety or treatment (depending on the experiment). Data from respiration experiments are presented as estimated marginal means with s.e.m. Statistical significance was considered at the *P*\<0.05 level.

Results
=======

Diazepam actions in the VTA facilitate social competition and mitochondrial respiration in the NAc
--------------------------------------------------------------------------------------------------

We first studied the effects of an intra-VTA DZP infusion on behavioral and metabolic outcomes examined 30 min post treatment compared to vehicle-treated animals matched for equivalent anxiety levels ([Figure 1a](#fig1){ref-type="fig"}). Intra-VTA DZP at a dose (25 ng per hemisphere) that effectively reduced anxiety-like behavior ([Figure 1b](#fig1){ref-type="fig"}) without affecting total locomotor activity ([Supplementary Figures 1a and b](#sup1){ref-type="supplementary-material"}) in the elevated plus maze, enhanced social dominance in a social competition test ([Figure 2c](#fig2){ref-type="fig"}). However, this treatment did not affect social exploration in the social preference test ([Supplementary Figure 1c](#sup1){ref-type="supplementary-material"}).

The same intra-VTA DZP treatment, given to new cohorts of animals, led to an increase in mitochondrial respiration in the NAc ([Figure 1d](#fig1){ref-type="fig"}), while mitochondrial respiration in the VTA was not affected ([Figure 1e](#fig1){ref-type="fig"}). This increase in respiration was not due to an increase in mitochondrial content as quantitative PCR with reverse transcription analyses of mitochondrial DNA (mtDNA) copy number of NADH dehydrogenase subunits ND1 and ND4 indicated no differences in NAc mtDNA content between DZP- and vehicle-treated animals ([Figure 1f](#fig1){ref-type="fig"}). Furthermore, the observed increase in respiration seems not to be the result of uncoupling effects of DZP on NAc mitochondria, as DZP-treated animals did not show any change in the mRNA levels of uncoupling markers, such as uncoupling protein 2, in the NAc or medial prefrontal cortex (mPFC; [Supplementary Figure 2](#sup1){ref-type="supplementary-material"}). Instead, DZP treatment led to significantly enhanced ATP levels specifically in the NAc ([Figure 1g](#fig1){ref-type="fig"}), supporting the view that the DZP-induced increase in mitochondrial respiration is functional. Interestingly, when DZP was infused directly into the NAc ([Supplementary Figure 3a](#sup1){ref-type="supplementary-material"}), there were no effects on behavioral ([Supplementary Figures 3b and c](#sup1){ref-type="supplementary-material"}) or metabolic ([Supplementary Figure 3d](#sup1){ref-type="supplementary-material"}) measures, suggesting that the DZP-induced effects on the NAc region are directly engendered by the VTA projections, rather than through local alterations at the VTA itself. As several studies have implicated the dopaminergic pathway in social behaviors and motivation,^[@bib31],\ [@bib32]^ and the dopaminergic projection is one of the major projections from the VTA to the NAc, we hypothesized that the DZP-induced effects on the NAc might involve changes in dopamine release. Supporting a role for the induction of accumbal DA release in the effects of DZP, intra-VTA DZP infusion increased levels of dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) in the NAc ([Figure 1h](#fig1){ref-type="fig"} and [Supplementary Figure 4](#sup1){ref-type="supplementary-material"}) but not in other dopaminergic VTA-output regions ([Supplementary Figure 5](#sup1){ref-type="supplementary-material"}).

To determine whether the link between VTA-NAc social competition and mitochondrial respiration is functional, we examined whether the effects of intra-VTA DZP could be prevented by inhibiting mitochondrial respiration in the NAc. We reduced mitochondrial respiration by infusing a low dose (10 ng per 0.3 ul) of the mitochondrial complex I inhibitor, rotenone, into the NAc immediately prior to DZP infusion into the VTA. Although rotenone infusion alone did not affect social competition, pre-infusion of rotenone prevented the enhancing effects of intra-VTA DZP on social competition ([Figure 1i](#fig1){ref-type="fig"}), suggesting a causal involvement of NAc mitochondrial function in the actions exerted by DZP infusions in the VTA on social competition. In addition, and in support of this causal implication, we found in another cohort previously submitted to social competition that NAc mitochondrial respiratory measures correlated positively with their social dominance scores ([Supplementary Figure 6](#sup1){ref-type="supplementary-material"}).

Involvement of NAc D1 receptors in intra-VTA DZP effects on social competition and mitochondrial respiration
------------------------------------------------------------------------------------------------------------

Given the DA release induced by DZP treatment (see [Figure 1h](#fig1){ref-type="fig"}), we next examined whether intra-VTA DZP would activate specific dopamine receptor-containing neurons in the NAc. DZP treatment led to an enhancement of cFOS protein expression in D1-, but not D2-containing neurons in the NAc ([Figure 2a--c](#fig2){ref-type="fig"}). The same treatment did not induce changes in cFOS expression in specific dopaminoceptive neurons in other VTA dopaminergic projection regions, such as the mPFC and basolateral amygdala (BLA; [Supplementary Figure 7](#sup1){ref-type="supplementary-material"}). We then tested the relevance of DA activation in the NAc for social competition and mitochondrial respiration by micro-infusing D1 and D2 receptor agonists ([Figure 2d](#fig2){ref-type="fig"}). Intra-NAc infusion of the D1 receptor agonist SKF-38393 (300 ng per hemisphere) increased social competition whereas intra-NAc infusion of the D2 receptor agonist quinpirole had no effect ([Figure 2e](#fig2){ref-type="fig"}). We verified that the selected quinpirole dose is effective under our experimental conditions by confirming its formerly reported locomotor effects^[@bib33]^ in the open field ([Supplementary Figure 8](#sup1){ref-type="supplementary-material"}). Thus, these observations are in line and expand our previous findings that social competition invokes a specific activation of D1-containing cells in the NAc that positively correlates with the amount of offensive behavior exerted.^[@bib4]^ Furthermore, we found that intra-NAc infusion of the D1 receptor agonist SKF-38393 (300 ng/hemisphere) increased mitochondrial respiration in the NAc ([Figure 2f](#fig2){ref-type="fig"}).

We then explored whether NAc D1 receptors would be necessary for the behavioral and metabolic effects induced by intra-VTA DZP infusion ([Figure 2g](#fig2){ref-type="fig"}). We found that the enhancing effects of intra-VTA DZP (25 ng per hemisphere) on social competition ([Figure 2h](#fig2){ref-type="fig"}) and NAc mitochondrial respiration ([Figure 2i](#fig2){ref-type="fig"}) were prevented by intra-NAc infusion of the D1 receptor antagonist SCH-23390 (300 ng per hemisphere).

Next, given the rapid DZP effects observed on mitochondrial respiration and the lack of evidence for changes in mtDNA (see [Figure 1f](#fig1){ref-type="fig"}), we measured PKA-mediated protein phosphorylation. We found increased PKA-mediated protein phosphorylation after intra-VTA DZP infusion ([Figure 2j](#fig2){ref-type="fig"}). However, no change in total content of several measured mitochondrial proteins (that is, DRP1, mitofusin 1 (Mfn1), mitofusin 2 (Mfn2), complex I NDUFS4 subunit, C1orf163), including specific phosphorylated isoforms such as phosphorylated Dynamin-related protein (phospho-Drp1), were observed ([Supplementary Figure 9](#sup1){ref-type="supplementary-material"}).

Trait anxiety is associated with variation in NAc D1 receptors activation and mitochondrial function
----------------------------------------------------------------------------------------------------

As our pharmacological experiments highlighted a role for NAc D1 receptors in both social dominance and mitochondrial respiration, we investigated potential differences in the expression of DA receptors in the NAc between high and low-anxious rats. As shown before,^[@bib4]^ we first confirmed in a new cohort of animals that high-anxious animals have a disadvantage to win a social competition against low-anxious counterparts ([Figures 3a and b](#fig3){ref-type="fig"}) and exhibit lower levels of mitochondrial respiration in the NAc ([Figure 3c](#fig3){ref-type="fig"}) but not in the VTA ([Figure 3d](#fig3){ref-type="fig"}) compared to low-anxious animals. Then, using quantitative PCR with reverse transcription, we found significantly lower mRNA expression levels of D1 receptors and a trend for lower levels of D2 receptors in the NAc of high-anxious animals ([Figures 3e and f](#fig3){ref-type="fig"}). Subsequently, we compared cellular activation following a social competition challenge with basal activation in the NAc of high and low-anxious rats. For this purpose, we performed triple-labeled immunohistochemical analyses for co-labeled cFOS protein expression and markers for different NAc cellular subtypes. Only D1-containing cells in low-anxious rats following social competition exhibited significantly enhanced cFOS protein activation ([Figures 3g and h](#fig3){ref-type="fig"}). This was not observed in high-anxious rats and neither high- nor low-anxious animals exhibited a competition-induced increase in the activity of D2-containing cells, astrocytes (S100^+^) or cholinergic cells (VAChT^+^). Altogether, these findings suggest that D1 receptors might be critically implicated in the anxiety-related differences in social competition and NAc mitochondrial respiration.

Diazepam in high-anxious rats enhances social dominance and NAc mitochondrial respiration
-----------------------------------------------------------------------------------------

Given that diazepam enhanced social dominance, we first tested whether diazepam could revert the disadvantage of high-anxious rats to win a social competition test and then examined the involvement of the NAc in the effects ([Figure 4a](#fig4){ref-type="fig"}). Thus, we first injected diazepam systemically at a dose (i.p. 0.5 mg kg^−1^) that reduces anxiety-like behavior in the elevated plus maze ([Supplementary Figures 10a--c](#sup1){ref-type="supplementary-material"}) without affecting locomotor activity ([Supplementary Figure 10d](#sup1){ref-type="supplementary-material"}). This treatment given to high-anxious rats increased their social dominance against low-anxious animals well above the low dominance levels observed in equivalent contests by vehicle-treated high-anxious rats ([Figure 4b](#fig4){ref-type="fig"}). Social investigation or auto-grooming were not affected by diazepam treatment ([Supplementary Table 1](#sup1){ref-type="supplementary-material"}).

Furthermore, systemic diazepam treatment to high-anxious rats led to increased mitochondrial respiration in the NAc compared to vehicle-treated high-anxious rats ([Figure 4c](#fig4){ref-type="fig"}). Interestingly, and supporting the view of specificity for the observed effects in the NAc, the same diazepam treatment had no effect on mitochondrial respiration in the BLA ([Figure 4d](#fig4){ref-type="fig"}) or mPFC ([Figure 4e](#fig4){ref-type="fig"}). Most importantly, when high-anxious animals were tested for mitochondrial respiration 1 week after diazepam treatment, their levels did not differ from those of vehicle-treated high-anxious rats ([Figure 4f](#fig4){ref-type="fig"}), demonstrating that the effects of diazepam are transient and the mitochondrial function of diazepam-treated animals reverts to baseline with time. The enhanced mitochondrial function in the NAc in response to systemic diazepam is not restricted to high-anxious animals, as it was also observed in intermediate anxious rats ([Supplementary Figures 11a and b](#sup1){ref-type="supplementary-material"}) but not in low-anxious animals ([Supplementary Figures 11a and c](#sup1){ref-type="supplementary-material"}).

Finally, we obtained evidence indicating that the NAc is required for the effectiveness of diazepam to increase social competitiveness in high-anxious animals. Pharmacological inactivation of the NAc with muscimol (25 ng per hemisphere) completely blocked the facilitating effects of both systemic ([Figures 4g and h](#fig4){ref-type="fig"}) and intra-VTA ([Figures 4i and j](#fig4){ref-type="fig"}) diazepam treatment in high-anxious rats on social competition.

Discussion
==========

Benzodiazepines, the prototypic wide-spectrum anxiolytic drugs, can ameliorate social disturbances in clinical anxiety^[@bib34]^ and facilitate social competitiveness in several species.^[@bib10],\ [@bib11],\ [@bib12]^ Remarkably, the mechanisms involved in the social effects of benzodiazepines are largely unknown. Here, we identify the VTA as a major site of diazepam action on the facilitation of social dominance in rats and the NAc as a critical effector region. In the NAc, we pinpoint the causal engagement of mitochondrial function and the critical activation of D1 receptors on the facilitating effects of diazepam in social competitiveness and mitochondrial function.

Specifically, we show that low doses of diazepam administered either systemically or directly into the VTA, but not into the NAc, enhances social competitiveness. Diazepam even inverts the default submissive tendencies for high-anxious animals in their competition against low-anxious conspecifics. Our findings are in agreement with reports showing that benzodiazepines facilitate social dominance in different species,^[@bib10],\ [@bib11]^ particularly in subordinate animals,^[@bib10],\ [@bib12]^ and increase aggressive behavior in humans,^[@bib35]^ particularly on high-anxious individuals.^[@bib36]^ Note that the effects on social competence were so far reported for low doses; in fact, the opposite effect has been reported for high doses.^[@bib37]^ This is probably related to the fact that at higher doses benzodiazepines induce sedation; an effect mediated by overstimulation of the alpha-1 type GABAa receptors.^[@bib38]^ We also report that intra-VTA diazepam treatment enhances mitochondrial respiration in the NAc, which is in line with causal evidence implicating mitochondrial respiration in the NAc in the social rank attainment in rats.^[@bib4]^ In addition, we show that along with the facilitation of social dominance in high-anxious rats, systemic diazepam treatment selectively increases mitochondrial respiration in the NAc, but not in the BLA or mPFC. This is in agreement with a lack of involvement of the BLA in trait anxiety-related differences in social competition and mitochondrial function.^[@bib4]^ Critically, we present causal evidence for the involvement of mitochondrial respiration in the facilitating actions of diazepam in social competition, as reducing activation of NAc mitochondrial complex I with rotenone blocked the behavioral effects of intra-VTA diazepam.

The implication of the VTA in the diazepam effects was further supported by a lack of behavioral and metabolic effects in experiments involving intra-accumbal infusion of diazepam. The identification of the VTA as a critical site of action for the effects of diazepam on social competition and mitochondrial function expands the reported role for this region in the addictive effects of benzodiazepines^[@bib14]^ and in the mediation of anxiety-related behaviors.^[@bib39],\ [@bib40]^ VTA DA neurons project mostly to the NAc and mPFC and to a lesser extent to the hippocampus and amygdala. Here, we specifically tested and confirmed the critical involvement of the NAc in the facilitating effects of diazepam in social dominance. The relevance of the NAc in mediating intra-VTA diazepam actions is strongly supported by the activation of the NAc taking place in highly aggressive genetically selected low-anxious rats following an aggression test^[@bib41]^ and humans exposed to social comparison and competition.^[@bib25],\ [@bib26]^

Furthermore, our findings implicate the dopaminergic system in the mediation of diazepam effects. We show that intra-VTA diazepam treatment enhances dopamine and DOPAC in the NAc and infusion of a D1, but not D2, agonist into the NAc facilitates social dominance and accumbal mitochondrial respiration. In the NAc, D1 and D2 receptors are mainly expressed at the inhibitory medium spiny neurons. Interestingly, a recent study demonstrated that enhancing the activity of D1-, but not D2-containing medium spiny neurons, promoted resilience after chronic social defeat stress.^[@bib42]^ In line with this notion, we observed that D1-, but not D2-containing cells in the NAc were activated upon intra-VTA DZP infusion. Importantly, the facilitation of social competition and accumbal mitochondrial respiration induced by intra-VTA diazepam infusion were completely blocked by antagonizing D1 receptors in the NAc. This is particularly relevant as we also show here that, compared to low-anxious animals, the competitively disadvantageous high-anxious rats display lower D1 receptor expression levels and lack of activation in D1-containing cells in the NAc following exposure to the social competition test. Although the accumbal DA system was previously shown to be engaged in social exploration^[@bib43],\ [@bib44]^ and interaction,^[@bib45]^ our findings for diazepam effects were specific for social competition as, under our experimental conditions, social exploration and auto-grooming remained unaltered following intra-VTA diazepam administration. Previously, a link between anxiety and dopamine activity in the NAc was suggested;^[@bib46],\ [@bib47],\ [@bib48]^ our findings confirm this link in rats and critically implicate D1-dependent actions on accumbal mitochondrial function in the behavioral effects of benzodiazepines.

Another key novel finding from our study is the involvement of D1 receptor activation in the enhancement of accumbal mitochondrial respiration. Whereas chronically high cytosolic dopamine levels, occurring under certain neuropathological conditions---such as schizophrenia or Parkinson's disease---have been suggested to impair mitochondrial function through direct interaction with the mitochondrial electron transport system,^[@bib49],\ [@bib50]^ the D1-mediated effects reported here may not be directly mediated by dopamine itself but are likely to be postsynaptic and---according to our findings---presumably involve D1 signaling pathways. Notably, dopamine activation of D1 receptors stimulates cyclic AMP and PKA signaling^[@bib51]^ and cyclic AMP and PKA phosphorylation of mitochondrial proteins regulate mitochondrial bioenergetics. Although knowledge is still scarce, emerging evidence points to a key role for extra-mitochondrial cyclic AMP on mitochondrial respiratory activity, involving mechanisms such as modulation of complex proteins from the electron transport system or phosphorylation of proteins---such as the fission protein Drp1---that regulate mitochondrial morphology.^[@bib52]^ In particular, PKA-mediated phosphorylation has been shown to enhance respiration^[@bib53],\ [@bib54],\ [@bib55]^ and the dimerization and activity of ATP synthase, improving ATP production.^[@bib56]^ In agreement with the potential involvement of this mechanism of action in our study, we found evidence for increased PKA-dependent protein phosphorylation in the NAc following intra-NAc infusion of DZP. Furthermore, the ERK pathway has also been involved in the mediation of converging dopamine and glutamate signals^[@bib51]^ and ERK has recently been found to translocate not only to the nucleus but also to mitochondria.^[@bib57]^ A full elucidation of the mechanisms by which D1 signaling modulates accumbal mitochondrial function following diazepam administration warrants future research.

High-trait anxiety provides susceptibility for the development of psychopathologies under stress^[@bib6],\ [@bib58],\ [@bib59]^ and high-anxious humans as well as rats appear particularly disadvantaged in stressful competitive encounters.^[@bib2],\ [@bib4]^ Previously, we demonstrated that differences in trait anxiety are related to increased mitochondrial respiration in the NAc and different expression levels of social dominance. We now show that the anxiolytic benzodiazepine diazepam reduces this anxiety and boosts social dominance. The facilitating effects of diazepam injected peripheral or infused intra-VTA on mitochondrial function in the NAc presumably involve the activation of NAc D1 receptors and downstream signaling effects on mitochondrial targets ([Figure 5](#fig5){ref-type="fig"}). Although it is tempting to speculate, our findings do not automatically imply the inverse; namely that anxiety can be treated by affecting mitochondrial respiration. Here, our results demonstrate that intact mitochondrial function in the NAc is critical for the effects of diazepam on social dominance. These results strongly support a critical role for mitochondrial respiration and bioenergetics in social behavior and highlight the involvement of the NAc in social dominance. We suggest that the increased accumbal energy metabolism, as invoked by diazepam, could lead to a heightened motivational state experienced by high-anxious animals, thereby shifting their decision-making process from forfeiting to perseverance.
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![DZP infused into the VTA reduces anxiety, and enhances social competition and mitochondrial respiration of the NAc. The effects of intra-VTA DZP or vehicle (saline, (SAL)) were studied on anxiety-like behavior on the EPM, social competition and the nucleus accumbens was examined for mitochondrial respiration and neurotransmitter release using microdialysis (**a**). Intra-VTA administration of DZP (*N*=23 SAL, 13 DZP) had an anxiolytic effect, increasing time spent on the open arms of the EPM (**b**), (*t*=2.88, df=34, *P*=0.007) and increased social competition for anxiety-matched animals (*N*=15 pairs) above chance level (**c**), (*t*=3.81, df=14, *P*=0.002). This treatment (*N*=4/group) also enhanced mitochondrial respiration in the NAc ((**d**) complex I \[F~(1,6)~=8.88; *P*=0.025\], complex I+II (F~(1,6)~=11.85; *P*=0.014), ETS (F~(1,6)~=12.14; *P*=0.013), ETS CII (F~(1,6)~=7.43; *P*=0.03)). Intra-VTA DZP did not affect mitochondrial respiration of the VTA as compared to vehicle (saline (SAL)) injected controls (**e**), (complex I (F~(1,6)~=1.23; *P*=0.31), complex I+II (F~(1,6)~=1.79; *P*=0.23), ETS (F~(1,6)~=0.925; *P*=0.37), ETS CII (F~(1,6)~=1.02; *P*=0.35), *N*=4/group)) or mtDNA copy number levels for ND1 (**f**), (*t*=0.211, df=20, *P*=0.85, *N*=10 SAL, *N*=12 DZP)) or ND4 (**f**), (*t*=0.015, df=20, *P*=0.99, *N*=10 SAL, *N*=12 DZP)). DZP or vehicle (saline, SAL) was i.p. injected after which the mPFC, NAc, BLA and VTA were taken out by microdissection. ATP levels were increased only in the NAc (**g**), mPFC (*t*=0.01, df=12, *P*=0.99); NAc (*t*=2.366, df=10, *P*=0.03, *N*=13 SAL, *N*=11 DZP); BLA (*t*=0.61, df=12, *P*=0.92)). Intra-VTA DZP increased the accumbal levels of accumbal dopamine, (**h**), treatment effect F~(1,7)~=8.55, *P*=0.022 with post test at 40 min *t*=4.29, *P*\<0.001). The effects of intra-VTA DZP could be blocked by intra-NAc pre-infusion with rotenone (ROT) (**i**, interaction effect \[F~(1,43)~=4.59, *P*=0.038\] with post test DZP-VEH vs DZP-ROT (*t*=2.54, df=43, *P*=0.015)). Data are mean±s.e.m. (\**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001, unpaired Student\'s *t*-test (**b**and**f**), one-sample *t*-test against chance level (**c**), or against vehicle-treated controls (**g**) or two-way ANOVA with repeated measures (**h**) and without (**i**)). Respiration data (**d** and **e**) are presented as estimated marginal means±s.e.m. of oxygen flux per mg tissue (\**P*\<0.05, linear mixed model). See also [Supplementary Figures 1--6](#sup1){ref-type="supplementary-material"}. ANOVA, analysis of variance; BLA, basolateral amygdala; DZP, diazepam; EPM, elevated plus maze; mPFC, medial prefrontal cortex; NAc, nucleus accumbens; VAT, ventral tegmental area.](mp2017135f1){#fig1}

![The dopamine D1 receptor in the NAc is critical for the expression of social competition. Intra-VTA infusion of DZP (**a**) led to significant cFOS protein activation of D1-, but not D2-containing neurons in the NAc (**b**and**c**) D1^+^ (*t*=6.18, df=17, *P*\<0.0001, *N*=10 SAL, *N*=9 DZP), D2^+^ (*t*=0.433, df=18, *P*=0.67, *N*=10 SAL, *N*=10 DZP). Intra-NAc infusion of a D1-like agonist (D1ago, SKF-38393, 300 ng per 0.3 μl, *N*=12 pairs) increased social competition while a D2-like agonist (D2ago, quinpirole, 300 ng per 0.3 μl, *N*=12 pairs) had no effects on social competition against vehicle (saline, (SAL)) infused controls (**d**and**e**), D1ago: *t*=2.69, df=11, *P*=0.02; D2ago: *t*=0.61, df=10, *P*=0.55). Intra-NAc infusion of the D1-like agonist (*N*=14 D1ago, *N*=16 SAL) increased mitochondrial respiration of the NAc (**d**and**f**), complex I (F~(1,22.4)~=11.79; *P*=0.002), complex I+II (F~(1,28)~=7.33; *P*=0.01)). Intra-NAc infusion of the D1-like antagonist (*N*=7 pairs DZP/D1anta) blocked the effect of intra-VTA infusion of diazepam on social competition (VTA-diazepam-bar is replicated from [Figure 1d](#fig1){ref-type="fig"} for comparison (**g**and**h**, interaction effect (F~(1,40)~=4.63, *P*=0.038) with post-tests VTA-VEH/NAc-VEH vs VTA-DZP/NAc-VEH (*t*=2.04, *P*=0.048) and VTA-DZP/NAc-VEH vs VTA-DZP/NAc-ROT (*t*=2.09, *P*=0.04)). The intra-NAc infusion of the D1-like antagonist (*N*=4 DZP/VEH, *N*=5 DZP/D1anta) also prevented the increase in NAc mitochondrial respiration induced by diazepam infusion into the VAT (VAT (**g**and**i**) complex I (F~(1,7)~=48.7; *P*\<0.0001), complex I+II (F~(1,7)~=38.1; *P*\<0.0001), ETS (F~(1,7)~=52.7; *P*\<0.0001), ETS CII (F~(1,7)~=10.6; *P*=0.01)). Intra-VTA diazepam infusion significantly increased PKA phosphorylation of NAc proteins (**j,** \[t=2.72, df=19, *P*=0.014, *N*=10 SAL, *N*=11 DZP\]). Data (**c, e, h**and**j**) are mean±s.e.m. (^t^p\<0.1, \**P*\<0.05, \*\*\**P*\<0.001, one-sample *t*-test against chance level (**e**), unpaired Student\'s *t*-test (**c**and**j**) or two-way ANOVA (**h**). Respiration data (**f, i**) are presented as estimated marginal means±SEM of oxygen flux per mg tissue (^t^p\<0.1, \**P*\<0.05, \*\*\**P*\<0.001, Linear Mixed Model). ANOVA, analysis of variance; DZP, diazepam; ETS, electron transport system; NAc, nucleus accumben; PKA, protein kinase A; VTA, ventral tegmental area.](mp2017135f2){#fig2}

![High anxious rats lack activation of D1-receptor expressing cells in the NAc. Social competition, mitochondrial respiration, mRNA expression for the dopamine D1- and D2 receptor and cellular activation using IHC were investigated in HA and LA rats (**a**). HA express levels of social competition below chance when matched to LA opponents (*N*=21 pairs) (**b**), *t*=2.24, df=20, *P*=0.037). HA animals (*N*=10) exhibit low levels of mitochondrial respiration in the NAc compared to LA counterparts (*N*=8) under basal conditions (**c**), complex I (F~(1,12.9)~=5.87; *P*=0.03), complex I+II (F~(1,12.5)~=7.46; *P*=0.02), ETS (F~(1,16)~=8.76; *P*=0.01)), but no differences were observed in the VTA (**d,** complex I (F~(1,10)~=1.34; *P*=0.27) complex I+II (F~(1,10)~=0.948; *P*=0.35) ETS (F~(1,9)~=0.902; *P*=0.37) ETS CII (F~(1,9)~=0.284; *P*=0.61), *N*=4/group). HA rats also exhibited lower mRNA levels for the dopamine D1-receptor (**e**, *t*=3.0, df=14, *P*=0.0096) and D2 receptors than LA rats (**f**, *t*=1.83, df=15, *P*=0.09, *N*=8/group). Although LA rats (*N*=7) show increased cFOS protein levels in D1-expressing cells in the NAc upon social competition (**g**and**h,** *t*=4.04, df=6, *P*=0.007), this increase was not observed for HA animals (**g**and**h**, *t*=0.38, df=6, *P*=0.72, *N*=7). D2-expressing cells, astrocytes and cholinergic cells were not activated upon social competition in either HA or LA animals. Data (**b**,**e**,**f** and **g**) are mean±s.e.m. (^t^*P*\<0.1, \**P*\<0.05, \*\**P*\<0.01, one-sample *t*-test against chance- (**b**) or basal levels (**h**) or unpaired Student\'s *t*-test (**e**and**f)**. Respiration data (**c**and**d**) are presented as estimated marginal means±s.e.m. of oxygen flux per mg tissue (^t^*P*\<0.1, \**P*\<0.05, linear mixed model). See also [Supplementary Figure 7](#sup1){ref-type="supplementary-material"}. IHC, immunohistochemistry; HA, high-anxious; LA, low-anxious; NAc, nucleus accumbens.](mp2017135f3){#fig3}

![DZP treatment enhances social competition of HA rats and increases mitochondrial respiration of the NAc. DZP (0.5 mg kg^−1^ i.p.) or vehicle (saline (SAL)) was administered to HA animals to investigate the effects on social competition and NAc mitochondrial respiration (**a**). Against social competition with LA rats, vehicle-treated HA rats (*N*=19) were disadvantaged, while HA animals treated with DZP (*N*=20) exhibited significantly increased competitiveness (**b**, *t*=2.80, df=37, *P*=0.008). This treatment also increased mitochondrial respiration in the NAc of HA rats (*N*=6/group) (**c**, complex I \[F~(1,10)~=9.78; *P*=0.01\], complex I+II \[F~(1,10)~=25.3; *P*=0.001\], ETS \[F~(1,10)~=9.16; *P*=0.01\], ETS CII \[F(1,10)=3.78; *P*=0.08)) but had no effect on mitochondrial respiration in the BLA (**d**, (complex I (F~(1,10)~=0.224; *P*=0.65), complex I+II (F~(1,10)~=0.182; *P*=0.68), ETS (F~(1,10)~=0.362; *P*=0.56), ETS CII (F~(1,10)~=0.073; *P*=0.79)), *N*=6/group) or mPFC (**e**, (complex I (F~(1,6)~=0.061; *P*=0.81), complex I+II (F~(1,6)~=0.003; *P*=0.96), ETS (F~(1,6)~=0.102; *P*=0.76), ETS CII (F~(1,6)~=0.040; *P*=0.85)), *N*=4/group). One week after DZP administration, mitochondrial respiration did not differ from saline-injected (SAL) controls (**f**, \[complex I (F~(1,6)~=0.197; *P*=0.67), complex I+II (F~(1,6)~=0.113; *P*=0.75), ETS (F~(1,6)~=0.417; *P*=0.54), ETS CII (F~(1,6)~=0.364; *P*=0.57)\], *N*=4/group). NAc inactivation by intra-NAc infusion of the GABAa agonist muscimol (MUS, *N*=5 pairs) blocked the effects of either systemic or intra-VTA DZP on social competition in HA, while HA animals infused intra-NAc with vehicle (*N*=5 pairs) exhibited DZP's boosting effects on social competition (**g** and **h**), systemic: *t*=2.74, df=8, *P*=0.025; (**i** and **j**), intra-VTA: *t*=2.46, df=8, *P*=0.039). Data (**b**, **h** and **j**) are mean±s.e.m. (\**P*\<0.05, \*\**P*\<0.01, unpaired Student\'s *t*-test). Respiration data (**c**,**d**, **e** and **f**) are presented as estimated marginal means±s.e.m. of oxygen flux per mg tissue (^t^*P*\<0.1, \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001, linear mixed model). See also [Supplementary Figures 11](#sup1){ref-type="supplementary-material"}. BLA, basolateral amygdala; DZP, diazepam; HA, high-anxious; LA, low-anxious; NAc, nucleus accumbens.](mp2017135f4){#fig4}

![Hypothesized neurobiological mechanisms underlying the effects of diazepam in the VTA on mitochondrial function in the NAc. Under basal conditions (top) dopaminergic neurons in the VTA are under inhibitory control by GABAergic interneurons (in blue) thereby moderating VTA dopamine release in the NAc. Diazepam (1) binds to GABAa receptors of the VTA GABAergic interneurons causing a disinhibition of local dopaminergic neurons (2) and, thereby, resulting in enhanced dopamine release in the NAc (3).^[@bib16]^ Then, in a dopamine D1 receptor-dependent process, mitochondrial function is enhanced. This boost in accumbal mitochondrial function, as evidenced by increased O~2~ respiration and elevated levels of ATP, is likely achieved through PKA-mediated phosphorylation of mitochondrial proteins that may comprise mitochondrial complex subunits (4 and 5) or other proteins. GABA,ϒ-aminobutyric acid; NAc, nucleus accumbens; VTA, ventral tegmental area.](mp2017135f5){#fig5}
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